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Summary. B-cells of the rheumatoid synovial tissue are 
a constant part of and, in some histopathological 
subtypes, the dominant population of the inflammatory 
infiltrate, located in the region of tissue destruction. The 
pattern of B-cell distribution and the relationship to the 
corresponding antigen-presenting cells (follicular 
dendritic reticulum cells: FDCs) show a great variety. B- 
cells may exhibit (i) a follicular organization forming 
secondary follicles; (ii) follicle-like patterns with 
irregularly formed FDC networks, and (iii) a diffuse 
pattern of isolated FDCs. Molecular analysis of 
immunoglobulin VH and V L  genes from human 
synovial B-cell hybridomas and synovial t issue 
demonstrates somatic  mutations due to antigen 
activation. The FDC formations in the synovial tissue 
may therefore serve as an environment for B-cell 
maturation, which is involved in the generation of 
autoantibodies. An autoantibody is defined as  
"pathogenic" if it fulfills the Witebsky-Rose-Koch 
criteria for classical autoimmune diseases: definition of 
the autoantibody; induction of the disease by transfer of 
the autoantibody; and isolation of the autoantibody from 
the disease-specific lesion. B-cells from rheumatoid 
synovial tissue show specificity for FcIgG, type I1 
collagen, COMP, sDNA, tetanus toxoid, mitochondrial 
antigens (M2), filaggrin and bacterial HSPs. The 
contributions of these antigens to the pathogenesis of RA 
are still hypothetical. A possible contribution could 
derive from crossreactivity and epitope mimicry: due to 
crossreaction, an antibody directed originally against a 
foreign infectious agent could react with epitopes from 
articular tissues, perpetuating the local inflammatory 
process. The characteristic distribution pattern, the 
localisation within the area of tissue destruction, the 
hypermutated IgVH and IgVL genes, and their exclusive 
function to recognize conformation-dependent antigens 
suggest a central role for B-cells in the inflammatory 
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process of rheumatoid arthritis. Therefore, the analysis 
of synovial B-cell hybridomas and experimental 
expression of synovial IgVH and IgVL genes will help 
to characterise the antigens responsible for the 
pathogenesis of rheumatoid arthritis. 
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Abreviations 
RA: rheumatoid arthritis; HSP: heat shock proteins; 
CDR: complementarity determining region; FR: 
framework region; IgVH: immunoglobulin heavy chain 
variable region; IgVL: immunoglobulin light chain 
variable region; COMP: cartilage oligomeric matrix 
protein; SLE: systemic lupus erithematosus; FDC: 
follicular dendritic reticulum cell. 
Introduction 
Intrasynovial B-cells (including B-lymphocytes and 
plasma cells) are a constant and dominating component 
(Fig. la,d) of the inflammatory infiltrate in rheumatoid 
arthritis (RA) (Randen et al., 1995; Krenn et al., 1996a; 
Stiehl, 1997). Histopathologically, the synovial B-cells 
may exhibit a follicular distribution (Fig. la,b) and may 
be located in the area of bone cartilage destruction (Fig. 
le), and finally there is a correlation between the serum 
level of rheuma factors  (RF) and the follicular 
organisation of the synovial B-cells (Randen et al., 
1995). These findings indicate a pathogenic role of 
synovial B-cells in RA. Analysis of the pathogenetic 
potential of synovial B-cells in RA leads to two 
important questions: 1) Does an antigen-activated B-cell 
maturation occur in the synovial tissue? 2) Against 
which antigens are these B-cells directed? 
The first question should provide clarification, 
whether the local accumulation of B-cells is antigen- 
dependent or antigen-independent. The second question 
may lead to the identification of antigens which are 







